Cronos Group, Inc. (CRON)
3.375
0.00 (0.00%)
USD |
NASDAQ |
Sep 01, 16:00
3.375
0.00 (0.00%)
After-Hours: 20:00
Cronos Group Shareholders Equity (Quarterly) : 1.069B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.069B |
| March 31, 2026 | 1.074B |
| December 31, 2025 | 1.094B |
| September 30, 2025 | 1.083B |
| June 30, 2025 | 1.082B |
| March 31, 2025 | 1.066B |
| December 31, 2024 | 1.064B |
| September 30, 2024 | 1.082B |
| June 30, 2024 | 1.059B |
| March 31, 2024 | 1.076B |
| December 31, 2023 | 1.100B |
| September 30, 2023 | 1.120B |
| June 30, 2023 | 1.140B |
| March 31, 2023 | 1.129B |
| December 31, 2022 | 1.144B |
| September 30, 2022 | 1.194B |
| June 30, 2022 | 1.288B |
| March 31, 2022 | 1.325B |
| December 31, 2021 | 1.337B |
| September 30, 2021 | 1.459B |
| June 30, 2021 | 1.633B |
| March 31, 2021 | 1.571B |
| December 31, 2020 | 1.711B |
| September 30, 2020 | 1.767B |
| June 30, 2020 | 1.665B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.716B |
| December 31, 2019 | 1.750B |
| September 30, 2019 | 1.623B |
| June 30, 2019 | 937.14M |
| March 31, 2019 | 726.25M |
| December 31, 2018 | 148.45M |
| September 30, 2018 | 171.71M |
| June 30, 2018 | 172.77M |
| March 31, 2018 | 101.83M |
| December 31, 2017 | 68.93M |
| September 30, 2017 | 53.99M |
| June 30, 2017 | 39.26M |
| March 31, 2017 | 37.95M |
| December 31, 2016 | 25.11M |
| September 30, 2016 | 23.26M |
| June 30, 2016 | 11.77M |
| March 31, 2016 | 8.668M |
| December 31, 2015 | 8.424M |
| September 30, 2015 | 5.408M |
| June 30, 2015 | 6.443M |
| March 31, 2015 | 8.005M |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | 0.1986M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Lexaria Bioscience Corp. | 4.738M |
| Target Group, Inc. (Canada) | -8.655M |
| Tilray Brands, Inc. | 1.614B |
| InMed Pharmaceuticals, Inc. | 6.892M |
| NervGen Pharma Corp. | 12.18M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.180B |
| Total Liabilities (Quarterly) | 62.42M |
| Debt to Equity Ratio | 0.0012 |
| Current Ratio | 16.18 |
| Net Debt Paydown Yield | 0.01% |